Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Keratin 36, a specific marker of tongue filiform papillae, is downregulated in squamous cell carcinoma of the mobile tongue

V. Brychtova, PJ. Coates, V. Hrabal, L. Boldrup, P. Fabian, B. Vojtesek, N. Sgaramella, K. Nylander,

. 2020 ; 12 (5) : 421-428. [pub] 20200226

Language English Country Great Britain

Document type Journal Article

Human keratin 36 (K36) is a member of the hair keratin family and is a marker of hair cortex differentiation. The human KRT36 gene is located on the long arm of chromosome 17 and belongs to the cluster of structurally unrelated acidic hair keratins. Recently, it has been reported that KRT36 mRNA is specifically expressed in normal tongue epithelium and downregulated in squamous cell carcinomas of the mobile tongue. Furthermore, KRT36 levels have been reported to be downregulated in clinically normal mobile tongue tissue that is adjacent to tumours, suggesting it could be a marker of pre-neoplastic changes. However, the exact role and the potential role of K36 in tongue tumour formation remains unclear. The aim of the present study was to investigate expression of K36 in a series of squamous cell carcinomas of the mobile tongue, normal mobile tongue and a small panel of other human tissues (normal tissue from the appendix, cervix, hair, lip, mamilla, nail, oesophagus, skin, thymus and vagina) and selected cancer tissue (cervical cancer, melanoma and basal cell carcinoma). Affinity purified polyclonal antibodies against K36 were generated and used for immunohistochemical analysis. The results revealed that in the normal tongue, K36 was detected specifically in the filiform papillae of the dorsal surface of the tongue. Additionally, none of the tongue cancer tissue samples were K36-positive. Immunostaining also revealed that K36 was expressed in nail beds, Hassal's corpuscles in the thymus and the hair cortex. However, K36 was not expressed in the squamous epithelia of the skin, cervix and oesophagus, and the squamous cells of cervical carcinomas, basal cell carcinoma or melanoma. The present data indicated that K36 may be inactivated in tumours of the tongue. However, whether this is part of the tumoural process or if it is an effect of the tumour itself remains to be elucidated.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20019250
003      
CZ-PrNML
005      
20210208135153.0
007      
ta
008      
201103s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.3892/mco.2020.2005 $2 doi
035    __
$a (PubMed)32257198
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Brychtova, Veronika $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
245    10
$a Keratin 36, a specific marker of tongue filiform papillae, is downregulated in squamous cell carcinoma of the mobile tongue / $c V. Brychtova, PJ. Coates, V. Hrabal, L. Boldrup, P. Fabian, B. Vojtesek, N. Sgaramella, K. Nylander,
520    9_
$a Human keratin 36 (K36) is a member of the hair keratin family and is a marker of hair cortex differentiation. The human KRT36 gene is located on the long arm of chromosome 17 and belongs to the cluster of structurally unrelated acidic hair keratins. Recently, it has been reported that KRT36 mRNA is specifically expressed in normal tongue epithelium and downregulated in squamous cell carcinomas of the mobile tongue. Furthermore, KRT36 levels have been reported to be downregulated in clinically normal mobile tongue tissue that is adjacent to tumours, suggesting it could be a marker of pre-neoplastic changes. However, the exact role and the potential role of K36 in tongue tumour formation remains unclear. The aim of the present study was to investigate expression of K36 in a series of squamous cell carcinomas of the mobile tongue, normal mobile tongue and a small panel of other human tissues (normal tissue from the appendix, cervix, hair, lip, mamilla, nail, oesophagus, skin, thymus and vagina) and selected cancer tissue (cervical cancer, melanoma and basal cell carcinoma). Affinity purified polyclonal antibodies against K36 were generated and used for immunohistochemical analysis. The results revealed that in the normal tongue, K36 was detected specifically in the filiform papillae of the dorsal surface of the tongue. Additionally, none of the tongue cancer tissue samples were K36-positive. Immunostaining also revealed that K36 was expressed in nail beds, Hassal's corpuscles in the thymus and the hair cortex. However, K36 was not expressed in the squamous epithelia of the skin, cervix and oesophagus, and the squamous cells of cervical carcinomas, basal cell carcinoma or melanoma. The present data indicated that K36 may be inactivated in tumours of the tongue. However, whether this is part of the tumoural process or if it is an effect of the tumour itself remains to be elucidated.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Coates, Philip J $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
700    1_
$a Hrabal, Vaclav $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
700    1_
$a Boldrup, Linda $u Department of Medical Biosciences, Umea University, SE-901 85 Umea, Sweden.
700    1_
$a Fabian, Pavel $u Department of Pathology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
700    1_
$a Vojtesek, Borivoj $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, CZ-656 53 Brno, Czech Republic.
700    1_
$a Sgaramella, Nicola $u Department of Medical Biosciences, Umea University, SE-901 85 Umea, Sweden.
700    1_
$a Nylander, Karin $u Department of Medical Biosciences, Umea University, SE-901 85 Umea, Sweden.
773    0_
$w MED00205361 $t Molecular and clinical oncology $x 2049-9450 $g Roč. 12, č. 5 (2020), s. 421-428
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32257198 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201103 $b ABA008
991    __
$a 20210208135152 $b ABA008
999    __
$a ind $b bmc $g 1586028 $s 1109448
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 12 $c 5 $d 421-428 $e 20200226 $i 2049-9450 $m Molecular and clinical oncology $n Mol Clin Oncol $x MED00205361
LZP    __
$a Pubmed-20201103

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...